The biological data visualization market size is estimated to be USD 489.2 million in 2022 and is expected to witness a CAGR of 12.54% during the forecast period 2023-2033. Increase in the use of visualization tools, rise in investments in bio-manufacturing and biotechnology are factors contributing to the market growth. Additionally, escalating research in genomics and proteomics, technological developments in analytical and business intelligence solutions, and demand for quicker decision-making are other factors supporting the market growth. However, user interface problems and the lack of computational consistency for data management is expected to hinder the growth.

Increase in the use of visualization tools is expected to propel the market growth during the forecast period. As a result of the big data field’s fast development and the volume and complexity of biological data, there has been an increase in the use of visualisation tools on a global scale. Additionally, adopting advanced analysis tools is required to meet the demand for quicker decisions. These methods allow for the fast extraction of important data from larger, disorganised data sources. These factors are anticipated to have an impact on the rate of tool adoption over the projection period.

Rise in investments in bio-manufacturing and biotechnology is predicted to fuel the market growth. The development of a robust biological information ecosystem that includes biologic data visualisation is intended to increase investments in biotechnology and biomanufacturing. As it is projected to promote biotechnology and manufacturing innovation while maintaining appropriate levels of privacy, security, and research ethics. Similar to this, the United States government stated in September 2022 that it would invest USD 14 million in the development of tools for AI-based biological data analysis. A further USD 20 million will be used to create a data infrastructure that will make it easier to share data for cancer research.

Segmentation

By Technique

The market is categorized into magnetic resonance imaging, microscopy, x-ray crystallography, sequencing, and others. In the global market, the sequencing segment accounted for the largest revenue share in 2022 owing to the fact that strong demand for tools and algorithms for biological research due to the vast amount of data created by sequencing that requires data management systems and solutions. A further factor driving demand for technological developments in information storage and management is the introduction of workflow management system solutions as Galaxy and Chipster According to estimates, the market’s fastest CAGR will be witnessed in the magnetic resonance imaging segment. For the extraction, processing, and display of brain models from MRI data, a number of MRI-based tools, including BrainVoyager, have been developed. Similarly, software solutions, including Cardiac Image Modeller created by the University of Auckland in New Zealand, are specialized for processing and analysing cardiac images.

By Platform

The market is divided into linux, windows, mac OS, and others. In 2022, windows the segment accounted for the highest revenue share due to the fact that the windows is one that is frequently used. Currently, Microsoft Windows 10 is installed on almost 90% of desktops and laptops worldwide. In comparison to other platforms, this operating system is easily available worldwide and has a longer lifespan. It possesses the world’s largest software library. The key benefit of adopting Windows is that it has excellent compatibility with all types of information visualisation tools. Compared to MAC OS and Windows, Linux is an open source operating system. Users will find it simple to use this operating system, which increases usability. However, this operating system has a more complicated version structure than Windows offers. According to Linux’s open-source nature, a large number of Linux-based operating systems, known as distros, are released, making it challenging to select the right version.

By Application

The market is segregated into structural biology and molecular modelling, cell and organism imaging, alignments, phylogeny, & evolution, systems biology, genomic analysis. In the global market, the genomic analysis segment accounted for the largest revenue share in 2022 owing to new product launches in this category, rising investment in the creation of new platforms, supportive approach toward the use of analytical solutions, and technological developments. Recent advancements in sequencing technology give information generation a special capacity. In the near future, market growth is anticipated to be driven by technological advancements. For instance, a team of academics created CoolBox in October 2021, a toolkit for visual interpretation of genomics data. The toolkit integrates well with the Python ecosystem and is user-friendly. CoolBox is expected to allow the researchers to create visualization plots and examine the information in different ways.

By End Use

The market is segmented into hospitals & clinics, pharma & biotech company, academic research, others. In 2022, the academic research segment accounted for the largest revenue share owing to the adoption of next-generation sequencing (NGS) and X-ray crystallography techniques in their research to incorporate data visualisation tools. Information analysis tools are also used increasing frequently as a result of government funding for supporting research at academic institutions using NGS platforms. For instance, the National Institutes of Health (NIH) offered academic institutions funds of USD 29.5 million in November 2019 for a brand-new human genome reference project. To construct a reference centre for the human genome, USD 12.5 million was given to the University of California, the European Bioinformatics Institute, and the Washington University. Additionally, the end-user with the fastest expected growth rate is predicted to be the pharmaceutical and biotechnology company segment. The increasing collaborations between research organizations and companies to develop visualisation tools and implement them are anticipated to significantly increase revenue generation. For instance, BGI Americas Corporation announced in January 2022 that it will collaborate with Gencove to provide customers with full sequencing solutions.

Regional Markets

In 2022, North America region accounted for the highest revenue in the biological data visualization market and is expected to maintain its dominance during the forecast period. This is attributed to the established bioinformatics framework, the expanding use of a number of computational techniques, and the widespread deployment of cutting-edge sequencing technology. The use of information visualisation tools is anticipated to increase over the next few years as a result of the extensive use of bioinformatics tools by academic and research institutions in their investigations of diverse molecular biology methodologies. The emergence of both public and private organisations with a focus on big data, computational technologies, and bioinformatics is another factor driving market expansion in the Asia Pacific region. One such instance is the HKUST Big Data Institute, which plays a significant leadership role in Data Science and Big Data research in Hong Kong and throughout the world by undertaking educational programmes and research projects in these fields. In the region of pharmaceutical R&D, fintech, and traditional Chinese medicine (TCM) service systems, for instance, HKUST declared in September 2022 that it would partner with the Applied Science and Technology Research Institute (ASTRI) to conduct research and encourage the sharing of technology, including big data analysis and AI.

Competitor Insights

Some of the key players operating in the biological data visualization market are 3M, Thermo Fisher Scientific, Inc., QIAGEN, ZEISS International, Olympus Corporation, General Electric Company, Agilent Technologies Inc., Oxford Instruments, and Clarivate.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

• For instance, Terra and Verily partnered with Microsoft to improve the company’s platform for life science and health research in January 2021. Access to Microsoft’s data, cloud, AI technologies, and worldwide network of more than 168,000 life science and health partners will be made available due to the agreement.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including technique, platform, application, and end use from 2023 to 2033.

Report Scope:

Segmentation: Biological Data Visualization Market Report 2022 – 2033

Technique (Revenue, USD Million), 2022 – 2033

• Magnetic Resonance Imaging
• Microscopy
• X-ray Crystallography
• Sequencing
• Others

Platform (Revenue, USD Million), 2022 – 2033

• Linux
• Windows
• Mac OS
• Others

Application (Revenue, USD Million), 2022 – 2033

• Structural Biology and Molecular Modelling
• Cell and Organism Imaging
• Alignments, Phylogeny, & Evolution
• Systems Biology
• Genomic Analysis

End Use (Revenue, USD Million), 2022 – 2033

• Hospitals & Clinics
• Pharma & Biotech Company
• Academic Research
• Others

By Region (Revenue, USD Million), 2022 – 2033

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA